antiVEGFhoidolla
antiVEGFhoidolla refers to the use of anti-vascular endothelial growth factor therapy in the treatment of eye diseases characterized by abnormal blood vessel growth and fluid leakage. These therapies aim to reduce retinal or choroidal neovascularization and vascular permeability, thereby stabilizing or improving vision.
Anti-VEGF agents work by inhibiting VEGF, a protein that promotes new vessel formation and increases vascular
Indications cover major retinal vascular diseases such as neovascular age-related macular degeneration, diabetic macular edema, diabetic
Administration is via intravitreal injection, usually performed in a clinical setting. Dosing regimens vary and can
Efficacy is demonstrated by gains or stabilization in visual acuity and reductions in central retinal thickness
Monitoring involves regular eye examinations, vision testing, and OCT imaging to assess fluid status and treatment